About this trial
This study aims to investigate the efficacy of transcranial direct current stimulation (tDCS) in patients with post-stroke aphasia (PSA) and to explore its potential neural mechanisms. The study will recruit PSA patients and provide them with 14 tDCS sessions over 7 days, along with speech therapy. Language Behavior Scale scores and resting-state functional MRI scans will be collected before and after the intervention. In addition, a retrospective comparison will be conducted of language function and resting-state fMRI changes in a group of PSA patients who received only speech therapy; these patients did not undergo any physical intervention but received only speech therapy. Changes in Language Behavior Scale scores and functional connectivity (FC) before and after treatment in the speech therapy-only group will be analyzed and compared with those in the tDCS intervention group.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients must be between 18 and 80 years of age
First stroke in the left hemisphere
Stroke onset within the past 12 weeks
Native Chinese speakers who were able to communicate normally prior to onset
Disqualifiers
Time since stroke onset exceeds 12 weeks
History of psychiatric or neurological disorders
History of surgery for severe head trauma, brain tumors, or brain abscesses
Severe articulation disorders
Trial design
Parallel
Treatments tested in this trial
transcranial direct current stimulation
Other interventionAs a non-invasive brain stimulation technique, tDCS offers advantages such as convenience, safety, and low cost. Its mechanism of action involves regulating neuronal activity in the brain by applying a weak direct current to the scalp.
Treatment groups
Trial outcomes
Primary outcomes
Aphasia quotient (AQ)
The Aphasia Battery of Chinese (ABC) is a standardized Chinese adaptation of the Western Aphasia Battery (WAB). The Aphasia Quotient (AQ) is a composite score that reflects the overall severity of language impairment. The AQ score ranges from a minimum of 0 to a maximum of 100. Higher scores indicate better language function (i.e., less severe impairment).
Secondary outcomes
rs-fMRI
Sponsors and contacts
Click on the lead sponsor to view all of their trials.